TLNRD1(4H)-2E_pET151
(Plasmid
#224068)
-
PurposeBacterial expression of the 4-helix bundle of TLNRD1 (residues 143-273) containing the mutations K192E/R233E, fused to an N-terminal hexa-histidine tag. TEV cleavage site
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 224068 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 * |
* Log in to view industry pricing.
Backbone
-
Vector backbonepET151/D-TOPO
- Backbone size w/o insert (bp) 5760
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert nametlnrd1
-
Alt namemesdc1
-
SpeciesH. sapiens (human)
-
Insert Size (bp)393
-
MutationK192E/R233E double mutant; prevents actin binding and CCM2 binding
-
Entrez GeneTLNRD1 (a.k.a. MESDC1)
- Promoter T7
-
Tag
/ Fusion Protein
- 6xHIS; V5 (N terminal on insert)
Cloning Information
- Cloning method Gene Synthesis
- 5′ sequencing primer T7 Fwd
- 3′ sequencing primer T7 Rev (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
TLNRD1(4H)-2E_pET151 was a gift from Ben Goult (Addgene plasmid # 224068 ; http://n2t.net/addgene:224068 ; RRID:Addgene_224068) -
For your References section:
TLNRD1 is a CCM complex component and regulates endothelial barrier integrity. Ball NJ, Ghimire S, Follain G, Pajari AO, Wurzinger D, Vaitkeviciute M, Cowell AR, Berki B, Ivaska J, Paatero I, Goult BT, Jacquemet G. J Cell Biol. 2024 Sep 2;223(9):e202310030. doi: 10.1083/jcb.202310030. Epub 2024 Jul 16. 10.1083/jcb.202310030 PubMed 39013281